BlackRock reports 6,041,219 DLB shares (10%)

BlackRock, Inc. amended a Schedule 13G to report beneficial ownership of 6,041,219 shares of Dolby Laboratories, Inc. Class A common stock, representing 10.0% of the class as reported.

Rhea-AI Filing Summary

BlackRock, Inc. amended a Schedule 13G to report beneficial ownership of 6,041,219 shares of Dolby Laboratories, Inc. Class A common stock, representing 10.0% of the class as reported. The filing lists 5,849,800 shares as sole voting power and 6,041,219 as sole dispositive power. The cover shows 05/31/2026 and the amendment is signed on 06/04/2026.

Insights

Institutional Ownership Analyst

BlackRock reports a 10.0% stake in Dolby with sole voting and dispositive control over listed shares.

BlackRock filed an amendment to a Schedule 13G showing beneficial ownership of 6,041,219 Class A shares (CUSIP 25659T107), with 5,849,800 shares held with sole voting power. The filing attributes holdings to Reporting Business Units within BlackRock.

The economic and voting positions reported are factual disclosures of holdings; further filings would show any changes in position or voting alignment.

Compliance & Regulatory Counsel

The amendment clarifies beneficial ownership under SEC Schedule 13G guidance for passive/qualified holders.

The filing cites SEC Release No. 34-39538 and states the reported shares reflect certain Reporting Business Units of BlackRock, excluding disaggregated business units. Exhibit references include a Power of Attorney and Item 7 subsidiary identification.

Legal implications are limited to disclosure obligations; further action depends on any future ownership threshold changes or different filing status.

Key Figures

Beneficial ownership: 6,041,219 shares Percent of class: 10.0% Sole voting power: 5,849,800 shares +3 more

6 metrics

Beneficial ownership 6,041,219 shares Class A Stock (CUSIP 25659T107)

Percent of class 10.0% Percentage of Class A shares reported

Sole voting power 5,849,800 shares Number of shares with sole power to vote (Item 4(i))

Sole dispositive power 6,041,219 shares Number of shares with sole power to dispose (Item 4(iii))

Filing date / signature 05/31/2026 / 06/04/2026 Cover date and signature date shown on amendment

CUSIP 25659T107 Identifier for Dolby Laboratories Class A stock

Key Terms

Schedule 13G/A, beneficially owned, sole dispositive power, Reporting Business Units

4 terms

Schedule 13G/A regulatory

"In accordance with SEC Release No. 34-39538 (January 12, 1998)"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned regulatory

"reflects the securities beneficially owned, or deemed to be beneficially owned"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 6041219"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Reporting Business Units other

"beneficial ownership of securities by certain business units (collectively, the "Reporting Business Units")"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does BlackRock report in Dolby Laboratories (DLB)?

BlackRock reports beneficial ownership of 6,041,219 Class A shares, representing 10.0% of the class. The Schedule 13G/A lists the share count and percentage and identifies sole voting power over 5,849,800 shares as of the filing.

What voting and dispositive powers does BlackRock list in the filing?

The filing shows sole voting power for 5,849,800 shares and sole dispositive power for 6,041,219 shares. Shared voting and dispositive powers are reported as zero in the Item 4 ownership breakdown.

What date is associated with the reported ownership in the amendment?

The cover displays 05/31/2026 and the amendment is signed on 06/04/2026. These dates appear on the cover and signature block and anchor the timing of the reported beneficial ownership.

Does the filing identify which BlackRock entities hold the shares?

The amendment attributes holdings to Reporting Business Units of BlackRock, Inc., not to unrelated business units. It states holdings reflect certain business units and excludes securities disaggregated under SEC Release No. 34-39538.

What exhibits accompany the Schedule 13G/A amendment?

Exhibit 24 (Power of Attorney) and Exhibit 99 (Item 7 subsidiary identification) are attached. The filing references Exhibit 99 for the subsidiary identification and Exhibit 24 for signature authority.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 12:12 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

DOLBY LABORATORIES, INC

(Name of Issuer)

Class A Stock

(Title of Class of Securities)

25659T107

(CUSIP Number)

05/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 25659T107

1

Names of Reporting Persons

BlackRock, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 5,849,800.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 6,041,219.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

6,041,219.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10.0 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: DOLBY LABORATORIES, INC
(b)	Address of issuer's principal executive offices: 1275 MARKET STREET SAN FRANCISCO CA 94103
Item 2.
(a)	Name of person filing: BlackRock, Inc. In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the "Reporting Business Units") of BlackRock, Inc. and its subsidiaries and affiliates. It does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units in accordance with such release.
(b)	Address or principal business office or, if none, residence: BlackRock, Inc., 50 Hudson Yards New York, NY 10001
(c)	Citizenship: See Item 4 of Cover Page
(d)	Title of class of securities: Class A Stock
(e)	CUSIP No.: 25659T107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 6041219
(b)	Percent of class: 10.0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 5849800
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 6041219
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of DOLBY LABORATORIES, INC. No one person's interest in the common stock of DOLBY LABORATORIES, INC is more than five percent of the total outstanding common shares.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BlackRock, Inc.

Signature:	Spencer Fleming
Name/Title:	Managing Director
Date:	06/04/2026

Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7